PGK1 and GRP78 overexpression correlates with clinical significance and poor prognosis in Chinese endometrial cancer patients

The aim of this study was to measure the expression patterns of PGK1 and GRP78 in normal endometrial tissues and endometrial carcinoma, and associations between their combined effects and the pathological features of endometrial carcinoma. We used 30 normal endometrial tissue samples and 130 endometrial carcinoma samples, and separately evaluated PGK1 and GRP78 protein expression by immunohistochemistry. Scores ranging from 0 to 9 were obtained by multiplying the percentage of positive cells by the staining intensity (0–3). Immunohistochemical analysis revealed increased PGK1 and GRP78 expression in the cytoplasm of endometrial carcinoma cells compared with that in normal endometrial tissues. High PGK1 expression positively correlated with the FIGO stage (P < 0.001), histological grade (P = 0.002), and lymph node status (P < 0.001). High GRP78 expression positively correlated with the pathological type (P = 0.0125), FIGO stage (P < 0.001), and lymph node status (P < 0.001). In addition, PGK1 overexpression was positively correlated with GRP78 overexpression in endometrial carcinoma patients (P < 0.001), and the concurrent expression of both oncogenes in endometrial carcinoma patients correlated significantly with the lymph node status (P < 0.001) and FIGO stage (P < 0.001). Patients with high PGK1 and GRP78 expression levels had poorer overall survival rates than those with low expression levels of both proteins (P < 0.001). Our results suggested that the co-occurrence of PGK1 and GRP78 expression is potentially an unfavorable factor for endometrial carcinoma progression.

[1]  C. Pirker,et al.  Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis. , 2017, Cancer letters.

[2]  C. Doillon,et al.  Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78 , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  Xin Liu,et al.  GRP78 Participates in PCA3-regulated Prostate Cancer Progression. , 2017, Anticancer research.

[4]  H. Xie,et al.  PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process , 2017, International journal of molecular sciences.

[5]  Sheng-Xiang Lin,et al.  17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  D. Klionsky,et al.  A novel role for a glycolytic pathway kinase in regulating autophagy has implications in cancer therapy , 2017, Autophagy.

[7]  Zhimin Lu,et al.  Protein kinase activity of the glycolytic enzyme PGK1 regulates autophagy to promote tumorigenesis , 2017, Autophagy.

[8]  B. Jiang,et al.  Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy. , 2017, Molecular cell.

[9]  J. Qin,et al.  Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis , 2017, Hepatology.

[10]  Lingyun Ji,et al.  Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. , 2016, Gynecologic oncology.

[11]  Zhimin Lu,et al.  PGK1 is a new member of the protein kinome , 2016, Cell cycle.

[12]  K. Aldape,et al.  Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. , 2016, Molecular cell.

[13]  Ya Cao,et al.  Role of multifaceted regulators in cancer glucose metabolism and their clinical significance , 2016, Oncotarget.

[14]  W. Lu,et al.  Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer , 2015, Medicine.

[15]  D. Lambert,et al.  Validation of endogenous control reference genes for normalizing gene expression studies in endometrial carcinoma. , 2015, Molecular human reproduction.

[16]  D. Pang,et al.  Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer , 2015, British Journal of Cancer.

[17]  Yingying Wang,et al.  GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the β-catenin signaling , 2014, Oncotarget.

[18]  H. Northoff,et al.  Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer. , 2013, International journal of oncology.

[19]  Dongyun Yang,et al.  The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival. , 2013, Gynecologic oncology.

[20]  X. Matías-Guiu,et al.  Molecular pathology of endometrial carcinoma , 2013, Histopathology.

[21]  Yuan-jie Zou,et al.  Over‐Expression of Cofilin‐1 and Phosphoglycerate Kinase 1 in Astrocytomas Involved in Pathogenesis of Radioresistance , 2012, CNS neuroscience & therapeutics.

[22]  Zongwei Li,et al.  Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. , 2012, Biochimica et biophysica acta.

[23]  T. Minegishi,et al.  GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer. , 2012, Gynecologic oncology.

[24]  G. Bifulco,et al.  Endoplasmic reticulum stress is activated in endometrial adenocarcinoma. , 2012, Gynecologic oncology.

[25]  Yi Zhang,et al.  Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. , 2011, The Biochemical journal.

[26]  M. Weller,et al.  Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer , 2010, International journal of cancer.

[27]  Huiling Yang,et al.  Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma , 2010, BMC Cancer.

[28]  Yu Wang,et al.  A glycolytic mechanism regulating an angiogenic switch in prostate cancer. , 2007, Cancer research.

[29]  Ying Liang,et al.  Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma , 2006, Proteomics.

[30]  Daohai Zhang,et al.  Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer* , 2005, Molecular & Cellular Proteomics.

[31]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[32]  P. Hogg,et al.  Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. , 2004, Biochimica et biophysica acta.

[33]  M. Tachibana,et al.  Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  B. Bernstein,et al.  Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism. , 1998, Biochemistry.